Your Messages Inbox
Your Article Summary
See Latest ArticlesHuman genome sciences begins delivery of first-in-class anthrax treatment to u.s. strategic national stockpile
Human Genome Sciences, 02/03/09
Human Genome Sciences, Inc. (Nasdaq: HGSI) announced that it has begun delivery of 20,000 doses of its human monoclonal antibody drug ABthrax (raxibacumab) to the U.S. Strategic National Stockpile for use in the treatment of inhalation anthrax.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Go Go Generics
PharmExec, 12/18/09
MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09
Almirall and Forest Laboratories to Expand Respiratory Collaboration with LAS100977
Forest Laboratories, 12/18/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Covidien Announces Definitive Agreement to Sell U.S. Radiopharmacies
Covidien, 12/18/09
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09
Article Search
Sponsor